207 related articles for article (PubMed ID: 15279701)
1. Innate immune responses in respiratory syncytial virus infections.
Krishnan S; Halonen M; Welliver RC
Viral Immunol; 2004; 17(2):220-33. PubMed ID: 15279701
[TBL] [Abstract][Full Text] [Related]
2. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
Piedimonte G
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455
[TBL] [Abstract][Full Text] [Related]
3. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
Shafique M; Wilschut J; de Haan A
Vaccine; 2012 Jan; 30(3):597-606. PubMed ID: 22120195
[TBL] [Abstract][Full Text] [Related]
4. Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response.
Harris J; Werling D
Cell Microbiol; 2003 Oct; 5(10):671-80. PubMed ID: 12969373
[TBL] [Abstract][Full Text] [Related]
5. The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.
Garg R; Shrivastava P; van Drunen Littel-van den Hurk S
Expert Rev Vaccines; 2012 Dec; 11(12):1441-57. PubMed ID: 23252388
[TBL] [Abstract][Full Text] [Related]
6. Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus.
Larrañaga CL; Ampuero SL; Luchsinger VF; Carrión FA; Aguilar NV; Morales PR; Palomino MA; Tapia LF; Avendaño LF
Pediatr Infect Dis J; 2009 Oct; 28(10):867-73. PubMed ID: 19738511
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of respiratory syncytial virus infection.
Tripp RA
Viral Immunol; 2004; 17(2):165-81. PubMed ID: 15279697
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus and pulmonary surfactant.
Griese M
Viral Immunol; 2002; 15(2):357-63. PubMed ID: 12081017
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.
Schijf MA; Lukens MV; Kruijsen D; van Uden NO; Garssen J; Coenjaerts FE; Van't Land B; van Bleek GM
PLoS One; 2013; 8(11):e81695. PubMed ID: 24303065
[TBL] [Abstract][Full Text] [Related]
10. Human genetics and respiratory syncytial virus disease: current findings and future approaches.
Choi EH; Lee HJ; Chanock SJ
Curr Top Microbiol Immunol; 2013; 372():121-37. PubMed ID: 24362687
[TBL] [Abstract][Full Text] [Related]
11. Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
Descamps D; Peres de Oliveira A; Gonnin L; Madrières S; Fix J; Drajac C; Marquant Q; Bouguyon E; Pietralunga V; Iha H; Morais Ventura A; Tangy F; Vidalain PO; Eléouët JF; Galloux M
J Virol; 2021 Oct; 95(22):e0091221. PubMed ID: 34431698
[TBL] [Abstract][Full Text] [Related]
12. Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines.
Zeng R; Cui Y; Hai Y; Liu Y
Virus Res; 2012 Aug; 167(2):138-45. PubMed ID: 22698878
[TBL] [Abstract][Full Text] [Related]
13. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression.
Farrag MA; Almajhdi FN
Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242
[TBL] [Abstract][Full Text] [Related]
14. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
[TBL] [Abstract][Full Text] [Related]
15. The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis.
Piedra FA; Mei M; Avadhanula V; Mehta R; Aideyan L; Garofalo RP; Piedra PA
PLoS One; 2017; 12(3):e0172953. PubMed ID: 28267794
[TBL] [Abstract][Full Text] [Related]
16. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses.
Sedeyn K; Schepens B; Saelens X
PLoS Pathog; 2019 Oct; 15(10):e1007984. PubMed ID: 31622448
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion.
Johnson TR
Expert Rev Vaccines; 2006 Jun; 5(3):371-80. PubMed ID: 16827621
[TBL] [Abstract][Full Text] [Related]
19. Platelets Modulate Innate Immune Response Against Human Respiratory Syncytial Virus In Vitro.
Kullaya VI; de Mast Q; van der Ven A; elMoussaoui H; Kibiki G; Simonetti E; de Jonge MI; Ferwerda G
Viral Immunol; 2017 Oct; 30(8):576-581. PubMed ID: 28783457
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the host immune response by respiratory syncytial virus proteins.
Schmidt ME; Varga SM
J Microbiol; 2017 Mar; 55(3):161-171. PubMed ID: 28243940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
